Boomerang Ventures Makes Seed-Stage Investment in SynchNeuro to Advance Brain-Based Non-Invasive Glucose Monitoring Technology

SynchNeuro is a Portfolio Company of Boomerang Ventures INDIANAPOLIS, IN / ACCESS Newswire / November 12, 2025 / Boomerang ...

Cognision Announces Partnership with Kynexis to Utilize its COGNISION(R) System in a Phase 2 Trial of KYN-5356 in Subjects with Schizophrenia

Cognision, provider of advanced neurobiomarker technology, announces its partnership with Kynexis to utilize the COGNISION(R) System in Kynexis' Phase 2 clinical trial of KYN-5356 in subjects with ...

Cognision Announces Partnership with Kynexis to Utilize its COGNISION® System in a Phase 2 Trial of KYN-5356 in Subjects with Schizophrenia

Cognision, provider of advanced neurobiomarker technology, announces its partnership with Kynexis to utilize the COGNISION® System in Kynexis' Phase 2 clinical trial of KYN-5356 in subjects with ...
FMIBlog

U.S. Brain Monitoring Systems Market Forecast 2025–2035: Growth Trends and Future Opportunities

The U.S. Brain Monitoring Systems Market is entering a transformative decade as demand surges for advanced neurodiagnostic ...
Medical Device Network

Beacon Biosignals secures $86m to advance AI-driven brain biomarker use

Beacon Biosignals has secured $86m in a Series B funding round aimed at expanding its neurodiagnostic dataset and furthering ...